Indeed, adverse effects of HIF-1α associated with activation on infection and pro-inflammatory responses, epileptogenesis, and pronounced and persistent defects of B cells in COVID-19 patients have also been reported [161,162,163]. Here, HIF1A is linked to COVID-19.